Table 2 Distribution of metastatic sites in patients with stage IV lung carcinoids

From: Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices

Site

Sites represented in pathological specimens

Sites Involved based on radiological data

N

% of metastatic samples (n = 93)

N

% of patients (n = 66)

Liver

31

33

49

74

Regional Lymph Nodes

13

14

42

64

Bone

9

10

37

56

Brain

6

6

21

32

Extra-thoracic Lymph Nodes

2

2

11

17

Adrenal

1

1

11

17

Peritoneum

0

0

8

12

Skin/Subcutaneous

10

11

8

12

Contralateral Lung

0

0

7

11

Pleura

3

3

7

11

Breast

2

2

5

8

Eye

0

0

5

8

Pancreas

0

0

4

6

Ovary

4

4

4

6

Other

12

13

23a

<5% for each site

  1. aOther sites (involved in ≤3 patients) included soft tissue, spleen, chest wall, kidney, salivary gland, pericardium, diaphragm, heart, gallbladder, and thyroid